A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
07/25/2022 | George Francis Lee | 2 min read
The red flowing through us might just be the next melanoma diagnostic tool.
05/13/2022 | Michael Schubert
A look at the last five years of publishing on liquid biopsy
04/27/2022 | Sponsored by Invitae
NSCLC biomarker testing can be valuable for both patient and pathologist
03/04/2022 | Matthew J. Baker, Paul Brennan
Spectroscopy-based liquid biopsy could offer an affordable, effective route to early brain tumor diagnosis
10/09/2021 | Michael Schubert
A new liquid biopsy test can allow easier, more accurate diagnosis of malignancy in patients who are predisposed to cancer
09/02/2021 | Michael Schubert
Adding new biomarkers to existing tests could give us a better view of the brain and the degenerative diseases that affect it
07/12/2021 | Liv Gaskill
Could a new prototype biosensor challenge the current gold standard method of breast cancer detection?
05/13/2021 | Liv Gaskill
Reliably stratifying patients with spinal cord injury is essential for optimal treatment – and serum cytokines may be the key
03/16/2021 | Liv Gaskill
Using a simple blood test to identify the tissue source and genes of dead cells may be a step forward for noninvasive biopsies
12/16/2020 | Keith Cannon, Prabha Nagarajan
With better assays comes the need for better controls – are liquid biopsies and cell line-derived controls a match made in heaven?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Genetic Counseling
The Future Lies in Phenomic Medicine
Trusted Bodies for PGx